Scientific Literature Search

Source record

Mitochondrial DNA transmission of the mitochondrial defect in Parkinson's disease.

Gu M, Cooper JM, Taanman JW, Schapira AH.

Ann Neurol · 1998-08-01

DOI: 10.1002/ana.410440207PMID: 9708539

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

The alpha-synuclein Ala53Thr mutation is not a common cause of familial Parkinson's disease: a study of 230 European cases. European Consortium on Genetic Susceptibility in Parkinson's Disease.

Vaughan J, Durr A, Tassin J, Bereznai B, Gasser T, Bonifati V, De Michele G, Fabrizio E, Volpe G, Bandmann O, Johnson WG, Golbe LI, Breteler M, Meco G, Agid Y, Brice A, Marsden CD, Wood NW.

Ann Neurol · 1998-08-01

DOI: 10.1002/ana.410440221PMID: 9708553

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Entacapone and motor fluctuations in Parkinson's disease.

Riggs JE.

Ann Neurol · 1998-08-01

DOI: 10.1002/ana.410440227PMID: 9708559

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Apolipoprotein E and Parkinson's disease.

Inzelberg R, Paleacu D, Chapman J, Korczyn AD.

Ann Neurol · 1998-08-01

DOI: 10.1002/ana.410440230PMID: 9708561

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Apolipoprotein E genotypes and age at onset of Parkinson's disease.

de la Fuente-Fernández R, Sellers A, Beyer K, Lao JI.

Ann Neurol · 1998-08-01

DOI: 10.1002/ana.410440231PMID: 9708562

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Experimental destruction of substantia nigra initiated by Parkinson disease immunoglobulins.

Chen S, Le WD, Xie WJ, Alexianu ME, Engelhardt JI, Siklós L, Appel SH.

Arch Neurol · 1998-08-01

DOI: 10.1001/archneur.55.8.1075PMID: 9708957

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Randomized, placebo-controlled study of tolcapone in patients with fluctuating Parkinson disease treated with levodopa-carbidopa. Tolcapone Fluctuator Study Group III.

Adler CH, Singer C, O'Brien C, Hauser RA, Lew MF, Marek KL, Dorflinger E, Pedder S, Deptula D, Yoo K.

Arch Neurol · 1998-08-01

DOI: 10.1001/archneur.55.8.1089PMID: 9708959

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Presymptomatic hypertension in progressive supranuclear palsy. Study Group on Atypical Parkinsonisms.

Fabbrini G, Vanacore N, Bonifati V, Colosimo C, Meco G.

Arch Neurol · 1998-08-01

DOI: 10.1001/archneur.55.8.1153PMID: 9708971

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Selegiline delays the onset of disability in de novo parkinsonian patients. Swedish Parkinson Study Group.

Pålhagen S, Heinonen EH, Hägglund J, Kaugesaar T, Kontants H, Mäki-Ikola O, Palm R, Turunen J.

Neurology · 1998-08-01

DOI: 10.1212/wnl.51.2.520PMID: 9710028

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Sleep-related violence, injury, and REM sleep behavior disorder in Parkinson's disease.

Comella CL, Nardine TM, Diederich NJ, Stebbins GT.

Neurology · 1998-08-01

DOI: 10.1212/wnl.51.2.526PMID: 9710029

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Suprathreshold levodopa doses, dyskinesias, and disability in advanced Parkinson's disease.

Horstink MW, Praamstra P.

Neurology · 1998-08-01

DOI: 10.1212/wnl.51.2.649PMID: 9710072

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Second International Symposium on the Treatment of Parkinson's Disease.

Mizuno Y.

Neurology · 1998-08-01

DOI: 10.1212/wnl.51.2_suppl_2.s1PMID: 9711972

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Records come from scientific sources. Bibliographic counts do not represent completed translations or editorial approvals.

107.521 articles found

Mitochondrial DNA transmission of the mitochondrial defect in Parkinson's disease.

The alpha-synuclein Ala53Thr mutation is not a common cause of familial Parkinson's disease: a study of 230 European cases. European Consortium on Genetic Susceptibility in Parkinson's Disease.

Entacapone and motor fluctuations in Parkinson's disease.

Apolipoprotein E and Parkinson's disease.

Apolipoprotein E genotypes and age at onset of Parkinson's disease.

Experimental destruction of substantia nigra initiated by Parkinson disease immunoglobulins.

Randomized, placebo-controlled study of tolcapone in patients with fluctuating Parkinson disease treated with levodopa-carbidopa. Tolcapone Fluctuator Study Group III.

Presymptomatic hypertension in progressive supranuclear palsy. Study Group on Atypical Parkinsonisms.

Selegiline delays the onset of disability in de novo parkinsonian patients. Swedish Parkinson Study Group.

Sleep-related violence, injury, and REM sleep behavior disorder in Parkinson's disease.

Suprathreshold levodopa doses, dyskinesias, and disability in advanced Parkinson's disease.

Second International Symposium on the Treatment of Parkinson's Disease.

Filters